Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    Active, B2C/B2B, Multiple product stages, Multiple funding stages, Pharma & Medical Biotechnology Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector (1)

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (4)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models (2)

    Product Stage (2)

    Employees 

    Location 

    Status (1)

    7 Startups 0 In the News 2 Recently Updated
    • Total Funding
      $417.5M
      Raised
      19
      Events
    • Private Funding
      $417.5M
      Raised
      18
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $0
      Raised
      1
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    ImmPACT Bio logo

    ImmPACT Bio

    CAR-T Cell Therapies for Treating Cancer
    2017 B2B 51-200 B $137M
    biotechnology
    biopharmaceutical
    life-sciences
    genetic-engineering
    medical-technologies
    cancer-therapy
    hospitals
    healthcare-providers
    oncology
    cell-therapy
    cancer
    Sealantium Medical logo

    Sealantium Medical

    Tissue Sealants and Hemostatic Agents
    2011 B2B 1-10 B $11.57M
    first-aid
    medical-technologies
    surgery
    biotechnology
    biodegradable
    polymers
    hospitals
    critical-care
    tissue-regeneration
    Immunorizon logo

    Immunorizon

    Acquired
    T-and NK-cell Engagers for Cancer Therapy
    2017 B2B 1-10 Acquired Undisclosed
    cancer-therapy
    immunology
    oncology
    antibodies
    biotechnology
    KAHR Medical logo

    KAHR Medical

    Fusion Proteins for Treating Cancer and Autoimmune Diseases
    2005 B2B 11-50 F $98.35M
    cancer
    biological-therapy
    drug-delivery
    drug-discovery
    pharmaceuticals
    autoimmune-diseases
    chronic-patients
    biopharmaceutical
    pharma-companies
    Prilenia Therapeutics logo

    Prilenia Therapeutics

    A clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders
    2018 B2B 11-50 B $144.5M
    drug-development
    pharmaceuticals
    neurology
    amyotrophic-lateral-sclerosis-(als)
    biotechnology
    parkinson
    degenerative-diseases
    SpliSense logo

    SpliSense

    RNA-based Treatment for Genetic Diseases
    2016 B2B 11-50 B $41.5M
    medical-technologies
    pharma-companies
    pharmaceuticals
    biotechnology
    drug-development
    treatments
    genetics
    TargetGene Biotechnologies logo

    TargetGene Biotechnologies

    Genome Editing for Living Organisms
    2012 B2B 1-10 B $0
    laboratories
    medical-technologies
    biotechnology
    genomics
    genetic-engineering
    academia
    genetics
    patent-pending

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    7 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $417.5M
      Raised
      19
      Events
    • Private Funding
      $417.5M
      Raised
      18
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $0
      Raised
      1
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    ImmPACT Bio logo
    Raised
    $137M
    ImmPACT Bio
    CAR-T Cell Therapies for Treating Cancer
    Founded:2017
    Business Model:B2B
    Employees:51-200
    Funding Stage:B
    Sealantium Medical logo
    Raised
    $11.57M
    Sealantium Medical
    Tissue Sealants and Hemostatic Agents
    Founded:2011
    Business Model:B2B
    Employees:1-10
    Funding Stage:B
    Immunorizon logo
    Raised
    Undisclosed
    Immunorizon
    Acquired
    T-and NK-cell Engagers for Cancer Therapy
    Founded:2017
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    KAHR Medical logo
    Raised
    $98.35M
    KAHR Medical
    Fusion Proteins for Treating Cancer and Autoimmune Diseases
    Founded:2005
    Business Model:B2B
    Employees:11-50
    Funding Stage:F
    Prilenia Therapeutics logo
    Raised
    $144.5M
    Prilenia Therapeutics
    A clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders
    Founded:2018
    Business Model:B2B
    Employees:11-50
    Funding Stage:B
    SpliSense logo
    Raised
    $41.5M
    SpliSense
    RNA-based Treatment for Genetic Diseases
    Founded:2016
    Business Model:B2B
    Employees:11-50
    Funding Stage:B
    TargetGene Biotechnologies logo
    Raised
    $0
    TargetGene Biotechnologies
    Genome Editing for Living Organisms
    Founded:2012
    Business Model:B2B
    Employees:1-10
    Funding Stage:B
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,